Lawyers for Elmiron Vision Loss Cases in Mississippi
The Drug, Approved for Patients with Interstitial Cystitis, May Damage
If you have been diagnosed with macular degeneration or pattern dystrophy
after using the drug Elmiron (pentosan polysulfate sodium, or PPS), there
may be a connection between this medication and your declining vision.
Patients in this cohort may be able to receive compensation for vision-related
treatment needs and other damages.
Elmiron is the only approved oral medication for interstitial cystitis
(IC), a painful condition that affects more than 1 million Americans.
Thus, the drug is widely prescribed. An article in The Review of Ophthalmology
it’s reached hundreds of thousands in search of relief from their chronic symptoms.
Elmiron was on the market for 22 years before scientists noticed its potential
links to vision loss. In the last 2 years, multiple studies have confirmed
retinal damage is associated with long-term use of the drug. For most
IC patients, Elmiron is meant to offer a permanent solution; however,
pharmaceutical companies only test drugs for a short period of time before
The (FDA) has not yet taken action to request a recall for Elmiron, but
as evidence has arisen regarding risks of taking this drug, many consumers
are choosing to stand up for themselves. Anyone who used Elmiron for an
extended time and then developed visual problems (often misdiagnosed as
macular degeneration or pattern dystrophy) likely has the right to pursue
compensation. If you or a loved one is in this situation, speak to our
attorneys today to learn what your legal rights are.
Call Richard Schwartz & Associates, P.A. at (601) 869-0696 or send us a message online if you think you have a valid claim. With 3 offices in Mississippi, our
team can connect with you.
What Symptoms Can Elmiron Cause?
types of vision loss experienced by long-time Elmiron users vary. Some retain perfect acuity,
while some see their vision rapidly deteriorate. Among the warning signs are:
- Blurred vision, especially while reading
- Slower adaptation to dark environments
- Metamorphopsia (distorted vision)
- Visual glare
- Blind spots
- Vision loss resulting in legal blindness
Because advanced cases of Elmiron-caused damage have symptoms similar to
dry (atrophic) age-related macular degeneration, many patients were incorrectly
diagnosed with this condition. If this sounds like it might apply to you,
or if you’re experiencing the symptoms listed above, you should
ask your eye doctor for a test to determine whether your long-term use
of Elmiron has caused retinal damage.
Determining Your Risk from Elmiron
Unfortunately, among patients who have used Elmiron for many years, the
risk of developing vision loss seems relatively high. Though scientists
note the sample sizes in existing studies may be insufficient in reflect
average patients’ experiences, a survey of almost 100 Elmiron users found
1 in 4 had experienced retinal damage. To put a name to this specific form of vision loss, researchers have
coined the term “PPS maculopathy.”
Specific Risk Factors
Scientists are still trying to understand how Elmiron kills retinal cells,
so they are not sure whether genetic or situational factors affect patients’
chances of experiencing vision loss. Current studies suggest a patient
becomes more likely to develop PPS maculopathy if they:
- Have a cumulative dosage greater than 1,000 g
- Take the drug for 7 or more years
Keep in mind patients who have not yet reached one or both of these thresholds
can still develop PPS maculopathy. If you think you have been affected,
we urge you to schedule a test with your doctor.
Learning if Elmiron Damaged Your Vision
Because the changes to patients’ vision are caused by the death of
retinal cells, PPS maculopathy is relatively easy to spot and diagnose.
Simple eye tests allow doctors to identify pigmentation abnormalities
and unusual deposits on the macula. Our attorneys can help you obtain
more medical information and find a knowledgeable ophthalmologist to provide
Elmiron Patients Deserve Compensation
Some drugs’ side effects are minor and, when given the chance, people
choose to risk them because they believe the medication will do more good
than harm. Others are so infrequent patients may opt to take a drug and
hope they are not injured. Elmiron patients, however, did not receive
a warning about the possibility of visual damage. They had no idea they
were at such a high risk of developing PPS maculopathy. For those whose
vision has been damaged, even
stopping the drug may not stop the retinal atrophy causing these issues. Their lives are forever changed. We are here to
help these patients fight for justice.
In lawsuits that involve
dangerous and defective drugs, plaintiffs may be able to receive compensation for:
- Related medical expenses
- Projected future medical needs
- Loss of wages
- Decreased earning capacity
- Loss of enjoyment of life
It’s hard to quantify the effects of having one of your senses severely
handicapped, but where are here to help you fight for the maximum possible
settlement. Richard Schwartz & Associates, P.A. has a team of supportive
attorneys who can guide you through the lawsuit process. If we do not
receive a settlement offer, we’ll litigate on your behalf. We’re
not afraid to take on Big Pharma in the courts, because we know it is
necessary for justice to be done.
Call our Mississippi attorneys now for a free consultation. We’re
available at (601) 869-0696.